Kamada Ltd. (KMDA)
NASDAQ: KMDA · Real-Time Price · USD
7.25
-0.13 (-1.76%)
Aug 14, 2025, 2:02 PM - Market open
Kamada Market Cap
Kamada has a market cap or net worth of $423.14 million as of August 14, 2025. Its market cap has increased by 25.41% in one year.
Market Cap
423.14M
Enterprise Value
368.82M
1-Year Change
25.41%
Ranking
Category
Stock Price
$7.25
Market Cap Chart
Since May 31, 2013, Kamada's market cap has increased from $346.50M to $423.14M, an increase of 22.12%. That is a compound annual growth rate of 1.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 424.40M | 21.22% |
| Dec 31, 2024 | 350.10M | 27.59% |
| Dec 29, 2023 | 274.40M | 52.78% |
| Dec 30, 2022 | 179.60M | -38.99% |
| Dec 31, 2021 | 294.40M | 12.58% |
| Dec 31, 2020 | 261.50M | -4.98% |
| Dec 31, 2019 | 275.20M | 36.71% |
| Dec 31, 2018 | 201.30M | 16.29% |
| Dec 29, 2017 | 173.10M | -12.80% |
| Dec 30, 2016 | 198.50M | 33.04% |
| Dec 31, 2015 | 149.20M | 9.22% |
| Dec 31, 2014 | 136.60M | -73.22% |
| Dec 31, 2013 | 510.10M | 47.22% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |